Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Prostate cancer

MRI/US-guided biopsy—a viable alternative to TRUS-guidance

MRI/ultrasonography (MRI/US)-fusion biopsy outperforms systematic ultrasonography-guided biopsy, detecting more high-grade prostate tumours while being less able to detect low-grade cancer, thus preventing overtreatment of indolent tumours. Any of several MRI-guided biopsy techniques has the potential, therefore, to replace systematic transrectal ultrasonography-guided prostate biopsies in the future.

Key Points

  • MRI-guided biopsy is rapidly emerging as an alternative to systematic transrectal ultrasonography (TRUS)-guided biopsy for accurately detecting and localizing aggressive prostate cancers

  • Different MRI-guided prostate biopsy methods include direct MRI-guided, MRI/US-fusion-guided, and cognitive-fusion-guided biopsy6

  • In the future, MRI-guided biopsy will inevitably replace systematic TRUS-guided prostate biopsies

  • Implementation of MRI/US-fusion-guided biopsies requires caution: good quality MR images and image interpretation is required, accurate segmentation and registration is essential for targeting tumour suspicious regions with MRI/US-fusion guidance, and small lesions have a chance of being missed using this technique

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Siddiqui, M. M. et al. Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur. Urol. http://dx.doi.org/10.1016/j.eururo.2013.05.059.

  2. Puech, P. et al. Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study. Radiology 268, 461–469 (2013).

    Article  Google Scholar 

  3. Delongchamps, N. B. et al. Prebiopsy magnetic resonance imaging and prostate cancer detection: Comparison of random and targeted biopsies. J. Urol. 189, 493–499 (2013).

    Article  Google Scholar 

  4. Sonn, G. A. et al. Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur. Urol. http://dx.doi.org/10.1016/j.eururo.2013.03.025.

  5. Barentsz, J. O. et al. ESUR prostate MR guidelines. Eur. Radiol. 22, 746–757 (2012).

    Article  Google Scholar 

  6. Moore, C. M. et al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: A systematic review. Eur. Urol. 63, 125–140 (2013).

    Article  Google Scholar 

  7. Hoeks, C. M. A. et al. Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: Detection of clinically significant prostate cancers. Eur. Urol. 62, 902–909 (2012).

    Article  Google Scholar 

  8. Hambrock, T. et al. Prospective assessment of prostate cancer aggressiveness using 3 T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. Eur. Urol. 61, 177–184 (2012).

    Article  Google Scholar 

  9. van de Ven, W. J. M., Hulsbergen-van de Kaa, C. A., Hambrock, T., Barentsz, J. O. & Huisman, H. J. Simulated required accuracy of image registration tools for targeting high-grade cancer components with prostate biopsies. Eur. Radiol. 23, 1401–1407 (2013).

    Article  Google Scholar 

  10. Hu, Y. et al. MR to ultrasound registration for image-guided prostate interventions. Med. Image Anal. 16, 687–703 (2012).

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Henk-Jan Huisman for assistance in discussion of content and contributions to writing this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jelle O. Barentsz.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

van de Ven, W., Barentsz, J. MRI/US-guided biopsy—a viable alternative to TRUS-guidance. Nat Rev Urol 10, 559–560 (2013). https://doi.org/10.1038/nrurol.2013.179

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2013.179

This article is cited by

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer